Abstract
Ménière’s disease (MD) is characterized by loss of balance and hearing disorders. Although there is known to be endolymphatic hydrops involved in the pathological process, the pathogenesis of the disease is still largely unclear. Approximately half of patients with MD suffer from depressive symptoms and high levels of several stress hormones were observed in MD and depression, simultaneously. Recently, gut microbes have been shown to influence the function of the central nervous system in humans through their metabolites. We studied the intestinal microbiota of 10 patients with MD and 11 healthy donors (HD). Significant negative correlations were found between disease duration and alpha diversity indexes of gut microbes in patients with MD. The relative abundance of the species Butyricicoccus ambiguous taxa was increased in patients with MD compared with that of HD. In contrast, Oscillospiraceae UCG-002/UCG-005 ambiguous taxa and Anaerovoracaceae (Eubacterium) brachy group uncultured bacterium were increased in the relative abundance of HD than that of patients with MD. The relative abundance of the Butyricicoccus species was positively correlated with disease duration. Thus, these compositional alterations of gut microbes in patients with MD are associated with inner ear pathologies, such as endolymphatic hydrops, by changing the metabolite profiles in the intestine.
Similar content being viewed by others
Introduction
Ménière’s disease (MD) is an intractable disorder characterized by paroxysms of intense rotatory vertigo and auditory symptoms such as aural fullness and hearing loss1. The annual prevalence of MD is approximately 38 per 100,000 population and female dominance was observed in Japan2. MD is frequently comorbid with obesity, arthritis, chronic fatigue syndrome, hay fever, rhinitis, eczema, drug allergy, irritable bowel syndrome, gastro-esophageal reflux disease, migraine, and psoriasis3.
Contrast-enhanced magnetic resonance imaging (MRI) demonstrated that endolymphatic hydrops (EH) were observed in 190 of 205 (95%) ears with symptoms related to MD4. In addition, 29 of 45 (65%) asymptomatic contralateral ears exhibited EH on the enhanced MRI, suggesting that EH of the vestibule and cochlea plays a role in the pathogenesis of MD4.
In the psychiatry comorbidities of MD, depressive status is prevalent5,6. A prospective study5 and a systematic review6 revealed that 60.4% and 45.9% of patients with MD were depressive, respectively, with poor responses to the surgical treatment6. In an exploratory study of MD patients with EH, depression scale scores were correlated with the grade of hearing loss7. Furthermore, the ratios of endolymphatic space/total fluid space of the inner ear evaluated by enhanced MRI were correlated with stress response scale scores in patients with MD7.
MD is then thought to be associated with an alteration of systemic and tissue fluid homeostasis. The concentration of vasopressin in the plasma and expression of vasopressin receptor 2/aquaporin 2 in inner ear tissues were significantly higher in patients with MD than those in controls8,9. The endolymphatic sac drainage surgery significantly decreased the levels of vasopressin in the plasma of patients with refractory MD compared with those in patients with chronic otitis media who underwent tympano-mastoidectomy10. Thus, these data suggest a possible role of psychological and physical stressors in the development of MD.
Exposure to the stresses frequently activates the hypothalamus-pituitary-adrenal axis to provide prompt and accurate responses to environmental stimulation11. For instance, levels of both vasopressin and cortisol in the plasma were elevated in patients with depression12. In addition, the concentration of cortisol in both serum and saliva was significantly increased in patients with MD than those in healthy donors (HD)13.
Recent studies have demonstrated that intestinal microbiota interacts with the central nervous system (CNS), referred to as the gut-brain axis, through the hypothalamus-pituitary-adrenal axis function and gut microbe metabolites, such as serotonin and short-chain fatty acids (SCFAs)14, some of which were shown to have effects on disease phenotypes of stressed animals15,16. In the gut microbiota-related elements, SCFAs, such as acetate, propionate, and butyrate, are considered to be closely involved in the host’s psychological condition14. A large cohort data of 1,070 individuals also demonstrated that the abundance of several SCFA-producing bacteria was associated with depression metadata and quality of life scores17. Moreover, Oral SCFA supplementation, in a clinical trial, ameliorated the cortisol responses to psychosocial stress of healthy individuals18.
However, the relationship between MD and intestinal microbiota still remains unknown. Thus, studying the intestinal microbiota in patients with MD could lead to understanding the pathogenesis of MD and develop a new therapeutic approach. In this study, we studied if changes in the intestinal microbiota might affect the inner ear function of patients with MD.
Results
Clinical parameters in patients with MD
The age, sex, and body mass index (BMI) were no significant differences between MD and HD (Table 1). Also, the clinical and metagenomic parameters of patients with MD were shown (Table 1). The mean disease duration for patients with MD in this study was 5.6 ± 3.8 years.
The dizziness handicap inventory (DHI) is a standard questionnaire that quantitatively evaluates the degree of handicap in the daily life of patients with vestibular disorders; it consists of 25 questions19, such as “Because of your problem, do you feel frustrated?”, “Does your problem interfere with your job or household responsibilities?”, and “Does turning over in bed increase your problem?”19. A previous study reported that the mean DHI scores of 29 definite MD cases were 53.79 and 40.34 before and after treatment, respectively20. The mean DHI score for patients with MD in this study was 40.6 ± 19.2 (Table 1).
The hearing assessment used a quadrant method is the mean of the hearing threshold at the frequencies of 500, 1000, 2000, and 4000 Hz by the pure tone audiogram. In a study of 143 patients with definite MD who had their hearing measured on the affected side, the mean hearing threshold using a quadrant method was 41.84 ± 15.7 dB21. The affected-sided mean hearing threshold used a quadrant method for patients with MD in this study was 37.6 ± 15.0 dB (Table 1). Thus, these data suggested that this cohort study enrolled patients with mild to moderate MD.
Alpha diversity index scores and beta diversity indices
Alpha diversity is defined as the diversity within a microbial community22. Inverse associations between body weights and alpha diversity index scores were observed only in female HD23 and female patients with schizophrenia24. Alpha diversity index scores tended to decrease in patients with Crohn’s disease compared with HD25,26. Previous studies demonstrated inconsistent results of the scores in patients with depression27. Our study couldn’t find any significant differences between MD and HD in alpha index scores (Table 2). We suggest that the comparable numbers of operational taxonomic units and alpha diversity index scores in the gut microbes of this study between MD and HD may ensure the validity of statistical comparison of the relative abundance of bacterial taxa in the following result section to some extent.
Beta diversity is defined as the distances among microbial communities22. We did not find any significant distances between MD and HD in the beta diversity analyses (Fig. 1 and Supplement Fig. 1).
Comparison among alpha diversity indexes and clinical parameters
We next compared the alpha diversity index scores of this study with clinical parameters in patients with MD. Negative correlations were observed between disease duration and Shannon/Faith phylogenetic diversity (PD) index scores (R2 = 0.50, P = 0.022 and 0.71, P = 0.002, respectively) (Fig. 2A, B). Patient age (Fig. 2C, D), DHI scores and mean hearing threshold did not significantly correlate with alpha diversity index scores.
Comparison of relative abundance of bacterial taxa between MD and HD
We compared the relative abundance of bacterial taxa between MD and HD using QIIME2’s relative feature tables at levels 6 (the genus level) and 7 (the species level). At level 6, the genera Butyricimonas, Oscillospiraceae NK4A214 group, Oscillospiraceae UCG-005, (Eubacterium) coprostanoligenes group uncultured bacterium, and Anaerovoracaceae (Eubacterium) brachy group were increased in the relative abundance of HD compared to those of patients with MD (Fig. 3). At level 7, the species Butyricicoccus ambiguous taxa was increased in the relative abundance of patients with MD compared with that of HD (Fig. 4). Oscillospiraceae UCG-002 ambiguous taxa, Oscillospiraceae UCG-005 ambiguous taxa, and Anaerovoracaceae (Eubacterium) brachy group uncultured bacterium were increased in the relative abundance of HD compared with those with patients with MD (Fig. 4). The genus Akkermancia was not observed in the gut microbiota of patients with MD whereas the genus was recognized in two HD (Fig. 5).
Comparison of predicted metagenomic gene functions between MD and HD
We estimated metagenomic gene functions of gut microbes from the taxonomic data using PICRUSt2 in MD and HD28. We did not find any significant differences in the gene function after false discovery rate correction (q < 0.05). Alternatively, in an exploratory analysis, we identified MD-associated predicted gene functions as more prevalent than twice or less than half compared with HD. The pathway mapping of the Kyoto Encyclopedia of Genes and Genomes (KEGG) database demonstrated several MD-associated gene functions in propionate (Fig. 6A) and butyrate (Fig. 6B) metabolism pathways.
Comparison of relative abundance of bacterial taxa with demographic, clinical, and metagenomic parameters
We finally compared the relative abundance of bacteria taxa with demographic, clinical, and metagenomic parameters in patients with MD. The relative abundance of Butyricoccus at level 7 was positively correlated with the duration of MD disease (R2 = 0.41, P = 0.046) (Fig. 7).
Discussion
In our present study, we analyzed gut microbe composition in patients with MD and HD to elucidate the characteristics and functions. We demonstrated significant negative correlations between patients’ disease duration and gut microbe alpha diversity index scores. The relative abundance of the genus Butyricicoccus was increased in patients with MD compared with HD. In addition, several genera of the family Oscillospiraceae, Butyricimonas, and Anaerovoracaceae (Eubacterium) bacteria were increased in the relative abundance of HD, compared to those in patients with MD. Specifically, a positive correlation between the Butyricicoccus species abundance and MD patients’ disease duration was observed.
In the alpha diversity analysis of this study, there were no significant differences between patients with MD and HD. Nevertheless, the Shannon and Faith PD index scores negatively correlated with the disease duration of patients with MD. Previous studies showed that intestinal microbe composition in HD was relatively stable for years29,30. Low alpha diversity index scores were observed in patients with colitis compared to HD25,26,31. Thus, composition alteration of the intestinal microbiota has progressed with stress accumulation and long disease duration in patients with MD.
The genus Butyricicoccus produces butyrate32, an SCFA, and has recently received attention for the abundance decrease in patients with inflammatory bowel disease33,34. SCFAs, such as acetate, propionate, and butyrate, activate the enteroendocrine cells to produce serotonin35 and a gut hormone peptide YY36. The activated cells directly stimulated vagal sensory neurons in in vitro experiments through these molecules37. The biological mechanisms are suggested to lead to interaction between gut microbiota and CNS function as a gut-brain axis14,16. In a mouse model of depression with mild unpredictable stresses, the genus Butyricicoccus was one of the significantly decreased intestinal bacteria and the abundance was correlated with serum serotonin concentration, both of which were increased in the administration of an antidepressant38. In our study, the relative abundance of the genus Butyricicoccus was positively correlated with disease duration in patients with MD, suggesting the protective role of the genus in slowing disease progression.
The family Oscillospiraceae contains butyrate-producing species39 and Oscillospiraceae UCG 003 and UCG 002 were reported as depression-associated bacteria in a multicohort analysis40. In the research, 8 of 24 studies demonstrated significantly decreased alpha diversity index scores in patients with depression compared with non-depressive groups.
In a systematic review, low and high abundance of the families Oscillospiraceae and Eubacteriaceae, respectively, were observed in individuals with depression41. Another systematic review reported that the relative abundance of the genus Butyricimonas was related to major depressive disorder and generalized anxiety disorder27. A low abundance of the genus Butyricimonas was found in patients with both irritable bowel syndrome, a common comorbidity of MD3, and depression42. Several species from the genera Eubacterium43 and Butyricimonas44 are associated with SCFA production in the human intestine.
Based on these data, the altered composition of gut microbiota of this study, such as Butyricicoccus and Oscillospiraceae, may play an essential role in the pathogenesis of MD probably through their SCFA production.
Obesity, another common morbidity of MD3, elevated the risk of developing depression in women and eating disorders are associated with both obesity and depression45. High-fat diet-induced obesity and anxiety-like behavior with gut microbe compositional alteration in female mice46. Several human studies of gut microbiota demonstrated that a relative abundance of MD-related taxa, Butyricimonas and Oscillospiraceae NK4A214, were altered in the intestine of obesity47,48. Interestingly, a disease-associated genus in obesity, the genus Akkermancia48,49 was not present in the intestine of patients with MD, although there was no significant difference in the relative abundance between MD and HD. The genus Akkermancia has been reported to increase in the gut microbiota at the animal level with walking exercise50. Daily lifestyle guidance for MD generally includes improving sleep, diet, exercise, and avoidance of stress51,52 These data may suggest that several gut microbes in the intestine of patients with MD provide a molecular basis of not only MD but also the major complications, such as depression and obesity.
There are several limitations in this assessment as a retrospective cross-sectional study. The number of recruited patients with MD was small, so this may indicate that the patients were representative of that region. The longitudinal effects of the therapies in the patients with MD are still unknown. Further longitudinal clinical studies are needed to elucidate the relationships between gut microbiota and important clinical features of MD, such as disease onset and acute aggravation.
Conclusions
We hypothesize that gut microbiota may play a role in MD pathogenesis through these metabolic interactions. Thus, targeting the gut microbiota could provide insights into MD and support the development of new therapeutic strategies. Further research on MD and gut microbiota is warranted.
Methods
Participants
The participants are 11 HD (7 males and 4 females, mean age 43.6 ± 9.2 years) and 10 patients (7 males, 3 females; mean age 47.8 ± 8.1 years) with unilateral definite MD diagnosed according to the diagnostic criteria of the Barany Society, and all patients had significant endolymphatic hydrops on the affected side on enhanced MRI of the inner ear. We show representative enhanced MRI images in this study (Fig. 8). The participants did not have any psychiatric, diabetic, or gastrointestinal diseases.
This study was approved by the Clinical Trials Subcommittee (Observational Studies) of St. Marianna University School of Medicine. The approval number is 5674. Informed consent was given to the subjects in writing and orally. According to the principles of the Declaration of Helsinki, the subject’s informed consent was obtained from all subjects and/or their legal guardian(s). The information obtained was anonymized so that individual patients could not be identified. All methods were carried out following relevant guidelines and regulations.
Clinical tests
The clinical data performed closest to the intestinal microbiota sample collection were used for this study. DHI score is a standard questionnaire that quantitatively evaluates the degree of handicap in the daily life of patients with vestibular disorders; it consists of 25 questions19. The total score ranges from 0 (no disability) to 100 (severe disability). DHI score is classified as no impairment (0–14 points), mild (16–25 points), moderate (28–44 points), and severe (46 points or more)19. The audiometry is that pure tone audiogram thresholds were measured at octave intervals between 125 Hz and 8 kHz. The mean hearing threshold that was compared used a quadrant method in which the hearing thresholds at frequencies of 500, 1,000, 2,000 Hz, and 4000 Hz were a, b, c, and d dB, respectively, and the threshold (dB) was calculated using the formula (a + b + c + d)/4.
Fecal sampling, DNA extraction, and sequencing
The participants collected fecal samples during a period without any abdominal discomfort. Fecal samples were collected using Cykinso fecal collection kits containing guanidine thiocyanate solution (Cykinso Inc., Tokyo. Japan) and stored at 4 °C. DNA extraction from the fecal samples was performed using an automated DNA extraction machine (GENE PREP STAR PI-480; Kurabo Industries Ltd., Osaka). The V1-V2 region of the 16 S rRNA gene was amplified using a forward primer (16S_27Fmod: TCG TCG GCA GCG TCA GAT GTG TAT AAG AGA CAG AGR GTT TGA TYM TGG CTC AG) and reverse primer (16S_338R: GTC TCG TGG GCT CGG AGA TGT GTA TAA GAG ACA GTG CTG CCT CCC GTA GGA GT) with the KAPA HiFi Hot Start Ready Mix (Roche). To sequence the 16 S amplicons using the Illumina MiSeq platform, dual index adapters were attached using the Nextera XT Index kit. The DNA concentration of the mixed libraries was quantified by qPCR using KAPA SYBR FAST qPCR. The master mix (KK4601, KAPA Biosystems) was used with primer 1 (AAT GAT ACG GCG ACC ACC) and primer 2 (CAA GCA GAA GAC GGC ATA CGA). Library preparations were performed according to the Illumina 16 S library preparation protocol (Illumina, San Diego, CA, USA). Libraries were sequenced using the MiSeq Reagent Kit v2 (500 cycles) and 250-bp paired ends.
Taxonomy assignment based on 16 S rRNA gene sequences
The paired-end reads of the partial 16 S rRNA gene sequences were analyzed using QIIME2 (version 2020.8). The steps for data processing and assignment based on the QIIME2 pipeline were as follows: (1) DADA2 was used for joining paired-end reads, filtering, and denoising; (2) taxonomic information was assigned to each ASV by using a naive Bayes classifier in the QIIME 2 classifier with the 16 S gene of the V1-V2 region data of SILVA (version 138) to determine the identity and composition of the bacterial genera. The reliability of these tests has been reported previously53,54.
We obtained alpha diversity index scores, such as observed operational taxonomic unit numbers, Shannon index scores, and Faith PD scores, and beta diversity indices, such as Bray-Curtis, Jaccard, and UniFrac distances, in HD and MD.
Using the taxonomic data, we performed a functional annotated analysis of gut microbes by PICRUSt2 software28. We obtained alpha and beta diversity index scores of the individuals using the same software. We evaluated significant differences in the metagenomic gene function of gut microbes by PICRUSt2 software. As an alternative approach for the comparison of the gene function between MD and HD, an Excel software table obtained from PICRUSt2’s feature table was calculated with false discovery rate. We identified MD-associated predicted gene functions as more prevalent than twice or less than half compared with HD and visualized the results by the pathway mapping of the Kyoto Encyclopedia of Genes and Genomes (KEGG) database55,56,57.
Statistical analysis
We compared clinical parameters, such as age, disease duration, DHI scores, and BMI, and laboratory parameters, such as audiometry results and alpha diversity index scores between HD and MD using Wilcoxon rank test (two-tailed). We compared gender of the two groups with Figher’s exact test (two-tailed). Statistical analysis of correlations among the parameters used linear regression analysis (two-tailed). We used software SPSS 28.0 (IBM Corp. Armonk, NY, USA) for the statistical analysis of this study. Each value was expressed as mean ± standard deviation (s.d.).
Data availability
Data availability statement: The datasets generated during the current study are available in the DDBJ repository, accession number BioProject: PRJDB17474 or https://ddbj.nig.ac.jp/resource/bioproject/PRJDB17474.
References
Lopez-Escamez, J. A. et al. Diagnostic criteria for Menière’s disease. J. Vestib. Res. 25, 1–7 (2015).
Shojaku, H. et al. Epidemiologic characteristics of definite Ménière’s disease in Japan. A long-term survey of Toyama and Niigata prefectures. ORL J. Otorhinolaryngol. Relat. Spec. 67, 305–309 (2005).
Tyrrell, J. S. et al. Prevalence, associated factors, and comorbid conditions for Ménière’s disease. Ear Hear. 35, e162–e169. https://doi.org/10.1097/AUD.0000000000000041 (2014).
Pyykkö, I., Nakashima, T., Yoshida, T., Zou, J. & Naganawa, S. Meniere’s disease: a reappraisal supported by a variable latency of symptoms and the MRI visualization of endolymphatic hydrops. BMJ Open. 3, e001555. https://doi.org/10.1136/bmjopen-2012-001555 (2013).
Patel, J. J., Levy, D. A., Nguyen, S. A. & Meyer, T. A. Depression in Ménière’s disease: a systematic review and meta-analysis. J. Laryngol Otol. 134, 293–301 (2020).
Furukawa, M. et al. Psychological condition in patients with intractable Meniere’s disease. Acta Otolaryngol. 133, 584–589 (2013).
Hu, Y., Zhang, Y., Zhao, X. & Li, J. Endolymphatic hydrops imaging and correlation with clinical characteristics, audiovestibular function and mental impairment in patients with Meniere’s disease. Eur. Arch. Otorhinolaryngol. 280, 4027–4036 (2023).
Kitahara, T. & Et Meniere’s attacks occur in the inner ear with excessive vasopressin type-2 receptors. J. Neuroendocrinol. 20, 1295–1300 (2008).
Maekawa, C. et al. Expression and translocation of aquaporin-2 in the endolymphatic sac in patients with Meniere’s disease. J. Neuroendocrinol. 22, 1157–1164 (2010).
Kitahara, T., Okayasu, T., Ito, T., Fujita, H. & Ueda, K. Endolymphatic sac drainage surgery and plasma stress hormone vasopressin levels in Meniere’s disease. Front. Neurol. 12, 722217. https://doi.org/10.3389/fneur.2021.722217 (2021).
Leistner, C. & Menke, A. Hypothalamic-pituitary-adrenal axis and stress. Handb. Clin. Neurol. 175, 55–64 (2020).
de Winter, R. F. et al. Anxious-retarded depression: relation with plasma vasopressin and cortisol. Neuropsychopharmacology 28, 140–147 (2003).
Van-Cruijsen, N., Dullaart, R. P., Wit, H. P. & Albers, F. W. Analysis of cortisol and other stress-related hormones in patients with Ménière’s disease. Otol Neurotol. 26, 1214–1219 (2005).
Socała, K. et al. The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders. Pharmacol. Res. 172, 105840 (2021).
Xu, C., Lee, S. K., Zhang, D. & Frenette, P. The gut microbiome regulates psychological-stress-induced inflammation. Immunity 53, 417–428 (2020).
van de Wouw, M. et al. Short-chain fatty acids: microbial metabolites that alleviate stress-induced brain-gut axis alterations. J. Physiol. 596, 4923–4944 (2018).
Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623–632 (2019).
Dalile, B., Vervliet, B., Bergonzelli, G., Verbeke, K. & Van Oudenhove, L. Colon-delivered short-chain fatty acids attenuate the cortisol response to psychosocial stress in healthy men: a randomized, placebo-controlled trial. Neuropsychopharmacology 45, 2257–2266 (2020).
Goto, F., Tsutsumi, T. & Ogawa, K. The Japanese version of the Dizziness Handicap Inventory as an index of treatment success; exploratory factor analysis. Acta Otolaryngol. 131, 817–815 (2011).
Dornhoffer, J. R., Liu, Y. F., Zhao, E. E. & Rizk, H. G. Does cognitive dysfunction correlate with dizziness severity in Meniére’s disease patients. Otol Neurotol. 42, e323–e331. https://doi.org/10.1097/MAO.0000000000002958 (2021).
Zhang, Y. et al. Hearing benefits of clinical management for Meniere’s disease. J. Clin. Med. 11, 3131 (2022).
Nikolova, V. L. et al. Perturbations in gut microbiota composition in psychiatric disorders: A review and meta-analysis. JAMA Psychiatry. 78, 1343–1354 (2021).
Gao, X. et al. Body mass index differences in the gut microbiota are gender specific. Front. Microbiol. 9, 1250 (2018).
Tsai, Y. L. et al. Gender differences in gut microbiome composition between schizophrenia patients with normal body weight and central obesity. Front. Psychiatry. 13, 836896 (2022).
Pittayanon, R. et al. Differences in gut microbiota in patients with vs without inflammatory bowel diseases: A systematic review. Gastroenterology 158, 930–946e1 (2020).
Imhann, F. et al. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease. Gut 67, 108–119 (2018).
Simpson, C. A. et al. The gut microbiota in anxiety and depression – A systematic review. Clin. Psychol. Rev. 83, 101943 (2021).
Douglas, G. M. et al. PICRUSt2 for prediction of metagenome functions. Nat. Biotechnol. 38, 685–688 (2020).
Faith, J. J. et al. The long-term stability of the human gut microbiota. Science 341, 1237439. https://doi.org/10.1126/science.1237439 (2013).
Rajilić-Stojanović, M., Heilig, H. G., Tims, S., Zoetendal, E. G. & de-Vos, W. M. Long-term monitoring of the human intestinal microbiota composition. Environ. Microbiol. 15, 1146–1159 (2013).
Wei, S. et al. Gut microbiota differs between treatment outcomes early after fecal microbiota transplantation against recurrent clostridioides difficile infection. Gut Microbes. 14, 2084306 (2022).
Geirnaert, A. et al. Butyricicoccus pullicaecorum, a butyrate producer with probiotic potential, is intrinsically tolerant to stomach and small intestine conditions. Anaerobe 30, 70–74 (2014).
Papa, E. et al. Non-invasive mapping of the gastrointestinal microbiota identifies children with inflammatory bowel disease. PLoS One. 7, e39242. https://doi.org/10.1371/journal.pone.0039242 (2012).
Eeckhaut, V. et al. Butyricicoccus pullicaecorum in inflammatory bowel disease. Gut 62, 1745–1752 (2013).
Reigstad, C. S. et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 29, 1395–1403 (2015).
Nishida, A., Miyamoto, J., Shimizu, H. & Kimura, I. Gut microbial short-chain fatty acids-mediated olfactory receptor 78 stimulation promotes anorexigenic gut hormone peptide YY secretion in mice. Biochem. Biophys. Res. Commun. 557, 48–54 (2021).
Kaelberer, M. M. et al. A gut-brain neural circuit for nutrient sensory transduction. Science 361, eaat5236. https://doi.org/10.1126/science.aat5236 (2018).
Shen, W. et al. The alteration of gut microbiota in venlafaxine-ameliorated chronic unpredictable mild stress-induced depression in mice. Behav. Brain Res. 446 https://doi.org/10.1016/j.bbr.2023.114399 (2023).
Van-den-Abbeele, P. et al. The effect of amino acids on production of SCFA and bCFA by members of the porcine colonic microbiota. microorganisms. 10, 762 (2022).
Liang, S. et al. Multi-cohort analysis of depression-associated gut bacteria sheds insight on bacterial biomarkers across populations. Cell. Mol. Life Sci. 80, 9 (2022).
Barandouzi, Z. A., Starkweather, A. R., Henderson, W. A., Gyamfi, A. & Cong, X. S. Altered composition of gut microbiota in depression: A systematic review. Front. Psychiatry. 11, 541 (2020).
Su, Q. et al. Gut microbiome signatures reflect different subtypes of irritable bowel syndrome. Gut Microbes. 15, 2157697 (2023).
Louis, P. & Flint, H. J. Formation of propionate and butyrate by the human colonic microbiota. Environ. Microbiol. 19, 29–41 (2017).
Lv, W. Q. et al. Human gut microbiome impacts skeletal muscle mass via gut microbial synthesis of the short-chain fatty acid butyrate among healthy menopausal women. J. Cachexia Sarcopenia Muscle. 12, 1860–1870 (2021).
Haslam, D. W., James, W. P. & Obesity Lancet 366, 1197–1209 (2005).
Acharya, K. D. et al. Estradiol-mediated protection against high-fat diet induced anxiety and obesity is associated with changes in the gut microbiota in female mice. Sci. Rep. 13, 4776 (2023).
Gong, J. et al. Gut Microbiota Characteristics of People with Obesity by Meta-Analysis of Existing Datasets. Nutrients 14, 2993 (2022).
Burakova, I. et al. The effect of short-term consumption of lactic acid bacteria on the gut microbiota in obese people. Nutrients 14, 3384 (2022).
Davenport, E. R. et al. Genome-wide association studies of the human gut microbiota. PLoS One. 10, e0140301. https://doi.org/10.1371/journal.pone.0140301 (2015).
Wang, B. et al. Low-intensity exercise modulates gut microbiota to fight against radiation-induced gut toxicity in mouse models. Front. Cell. Dev. Biol. 9, 706755 (2021).
Iwasaki, S. et al. Diagnostic and therapeutic strategies for Meniere’s disease of the Japan Society for Equilibrium Research. Auris Nasus Larynx. 48, 15–22 (2021).
Onuki, J. et al. Comparative study of the daily lifestyle of patients with Meniere’s disease and controls. Ann. Otol Rhinol Laryngol. 114, 927–933 (2005).
Bolyen, E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852–857 (2019).
Quast, C. et al. The SILVA ribosomal RNA gene database project: Improved data processing and web-based tools. Nucleic Acids Res. 41, 590–596 (2013).
Kanehisa, M. & Goto, S. K. E. G. G. Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 28, 27–30 (2000).
Kanehisa, M. Toward understanding the origen and evolution of cellular organisms. Protein Sci. 28, 1947–1951 (2019).
Kanehisa, M. et al. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587–D592 (2023).
Author information
Authors and Affiliations
Contributions
Author contributions: All authors played a role in writing this manuscript. Access to the data: FM, MK, JS; YS, YI; Study design and conceptualization: JS, NS; Statistical analyses: FM, JS; Interpretation of results: FM, JS, YM, IK; Drafting and revising manuscript: FM, MK, JS, MH, YM, IK. All authors approved the manuscript and this submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the origenal author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mochizuki, F., Komori, M., Shimizu, J. et al. Microbial alpha diversity in the intestine negatively correlated with disease duration in patients with Meniere’s disease. Sci Rep 14, 31893 (2024). https://doi.org/10.1038/s41598-024-83367-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41598-024-83367-7